Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization–embryo transfer cycles

详细信息    查看全文

• 作者：Johnny S. Younis ; Sofia Soltsman ; Ido Izhaki ; Orit Radin ; Shalom Bar-Ami ; Moshe Ben-Ami
• 关键词：GnRH antagonist ; oocyte meiotic status ; oocyte competence ; follicular recruitment
• 刊名：Fertility and Sterility
• 出版年：2010
• 出版时间：September 2010
• 年：2010
• 卷：94
• 期：4
• 页码：1350-1355
• 全文大小：102 K

文摘

Objective

To investigate whether early and short follicular administration of GnRH antagonist using the flexible protocol has the potential to improve IVF-ET clinical results.

Design

Prospective, controlled, randomized study.

Setting

University-affiliated assisted reproductive technology unit.

Patient(s)

Fifty-three consecutive infertile women were enrolled to the study and control groups.

Intervention(s)

Both groups were treated with recombinant FSH and the flexible GnRH antagonist protocol. Women in the study group were additionally supplemented with three injections of GnRH antagonist (0.25 mg/d on days 1, 2, and 3 of the menstrual cycle).

Main Outcome Measure(s)

Hormonal milieu, oocyte meiotic status, competence for normal fertilization, cleavage, and clinical pregnancy rate.

Result(s)

Both groups had comparable baseline characteristics. The duration of recombinant FSH treatment was significantly longer in the study group as compared with the control group (10.9 ± 3.1 and 9.7 ± 1.3 days, respectively). The number of follicles ≥14 mm and E₂ level on the day of hCG administration, number of retrieved oocytes, and endometrial thickness were similar between the two groups. However, the fertilization rate was significantly higher in the study as compared with the control group (85 % ± 16 % and 69 % ± 24 % , respectively). Moreover, the cumulative rate of mature first polar body oocytes was significantly higher in the study group as compared with the control group (93 % and 85 % , respectively). Concomitantly, day-3 FSH and LH levels after initiation of treatment were significantly lower in the study as compared with the control group (6.1 ± 2.4 mIU/mL vs. 7.2 ± 1.9 mIU/mL and 2.4 ± 1.6 mIU/mL vs. 5.6 ± 2.7 mIU/mL, respectively).

Conclusion(s)

Early and short follicular GnRH antagonist supplementation using flexible GnRH antagonist treatment improves the meiotic status and competence of retrieved oocytes. It seems that early and short pituitary shutdown has the potential to improve clinical results in IVF-ET GnRH antagonist cycles.